FibroGen Inc.’s filing revealed that its Director Henderson Jeffrey William unloaded Company’s shares for reported $2060.0 on Sep 01. In the deal valued at $1.03 per share,2,000 shares were sold. As a result of this transaction, Henderson Jeffrey William now holds 28,866 shares worth roughly $ 22804.14.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, Henderson Jeffrey William sold 2,000 shares, generating $3,820 in total proceeds. Upon selling the shares at $1.91, the Director now owns 30,866 shares.
Before that, Henderson Jeffrey William sold 2,000 shares. FibroGen Inc. shares valued at $5,380 were divested by the Director at a price of $2.69 per share. As a result of the transaction, Henderson Jeffrey William now holds 32,866 shares, worth roughly $25964.14.
BofA Securities downgraded its FibroGen Inc. [FGEN] rating to an Underperform from a a Neutral in a research note published on Monday, August 08, 2023; the price target was decreased to $2 from $4. PT values the company’s stock at a premium of 60.5 to its Monday closing price.
Price Performance Review of FGEN
On Monday, FibroGen Inc. [NASDAQ:FGEN] saw its stock fall -8.47% to $0.79. On the same session, the stock had its day’s lowest price of $0.78, but rose to a high of $0.89. Over the last five days, the stock has lost -16.61%. FibroGen Inc. shares have fallen nearly -95.07% since the year began. Nevertheless, the stocks have fallen -93.50% over the past one year. While a 52-week high of $25.69 was reached on 02/03/23, a 52-week low of $0.81 was recorded on 09/18/23. SMA at 50 days reached $1.6004, while 200 days put it at $13.8188. A total of 10.04 million shares were traded, compared to the trading of 8.48 million shares in the previous session.
Levels Of Support And Resistance For FGEN Stock
The 24-hour chart illustrates a support level at 0.7500, which if violated will result in even more drops to 0.7100. On the upside, there is a resistance level at 0.8600. A further resistance level may holdings at 0.9300. The Relative Strength Index (RSI) on the 14-day chart is 24.03, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1295, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.08%. Stochastics %K at 5.75% indicates the stock is a buying.
How much short interest is there in FibroGen Inc.?
A steep rise in short interest was recorded in FibroGen Inc. stocks on Aug 30, 2023, growing by 2.62 million shares to a total of 10.81 million shares. Yahoo Finance data shows the prior-month short interest on Jul 30, 2023 was 8.19 million shares. There was a rise of 24.24%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 14.51% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.89.
FibroGen Inc. [FGEN] – Who Are The Largest Shareholders?
In filings from PRIMECAP Management Co., it is revealed that the company now owns 13,677,588 shares, or roughly 13.93% of the outstanding FGEN shares. In other words, the investor’s shares have fallen by -449,109 from its previous 13-F filing of 14126697.0. Additionally, The Vanguard Group, Inc. increased 11.51% of its stake after which the total value it holdings stand at $9,198,421, while BlackRock Fund Advisors added 15.63% of its stake to hold $6.8 million in the firm. Over the last quarter, SSgA Funds Management, Inc. purchased 938,042 shares of FibroGen Inc., while Millennium Management LLC bought 1,179,416 shares. At present, Armistice Capital LLC is holding 4,356,000 shares valued at $4.18 million. Schroder Investment Management No owned 3,356,570 shares of the company at the time of its most recent 13F filing, worth $3.22 million.
According to FactSet, FibroGen Inc.’s share price will average $2.25 in the next year, based on opinions of analysts polled by the firm. This is up nearly 161.63 percent from its previous closing price of $0.86. Analysts expect FibroGen Inc. stock to reach the higher price of $2.50, while the lowest price estimate is $2.00. However, 5 analysts have rated FGEN stock as an Underweight in their predictions for 2023.